arrow_back Back to App

Dividing Allergy and Infectious Diseases Institute into three new institutes

This act restructures the National Institute of Allergy and Infectious Diseases, splitting it into three independent institutes: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases. This aims to better focus research and health programs, potentially leading to more effective treatments and prevention of diseases affecting citizens.
Key points
Three new research institutes are created, focusing on allergies, infectious diseases, and immune system disorders.
Directors of these new institutes will be appointed by the President and confirmed by the Senate for five-year terms, increasing public oversight.
The changes aim to streamline research and access to information on these specific disease groups, potentially improving healthcare.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_1768
Sponsor: Rep. Roy, Chip [R-TX-21]
Process start date: 2023-03-23
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

NIH Reform Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_1768.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-03-23.

What are the main provisions?

Key points include:

  • Three new research institutes are created, focusing on allergies, infectious diseases, and immune system disorders.
  • Directors of these new institutes will be appointed by the President and confirmed by the Senate for five-year terms, increasing public oversight.
  • The changes aim to streamline research and access to information on these specific disease groups, potentially improving healthcare.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Roy, Chip [R-TX-21].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health